Product Information
ROCKLATAN 0.02%-0.005% EYE DRP is a brand product labeled by Alcon Laboratories, Inc., priced at $139.4032 per ML under NDC 70727052925. Its NADAC has been published 372 times since Aug 21, 2019.
FDA first approved this application on Mar 12, 2019.
ROCKLATAN 0.02%-0.005% EYE DRP
netarsudil and latanoprost ophthalmic solution, 0.02%/0.005%Strength
.05; .2 mg/mL; mg/mL
Manufacturer
Alcon Laboratories, Inc.NDC
70727052925
Classification
Brand
Dosage Form
SOLUTION/ DROPS
Route
OPHTHALMIC; TOPICAL
Effective Date
9/23/2026
Active Ingredients
LATANOPROST; NETARSUDIL MESYLATEApproval Type
New Drug (NDA)
FDA Application
NDA208259FDA Approved
3/12/2019
On Market Since
3/12/2019
Pharmacological Classes
Price Statistics
The NADAC for ROCKLATAN 0.02%-0.005% EYE DRP has been published 372 times since Aug 21, 2019, and over the history we have for it it has risen 38.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $139.4032 per ML |
|---|---|
| All-time high | $139.6392 (May 13, 2026) |
| All-time low | $100.5940 (Aug 21, 2019) |
| 52-week high | $139.6392 |
| 52-week low | $135.4742 |
| Median price | $126.6973 |
| Average price | $124.0580 |
| Largest weekly change | +9.0% (Oct 2, 2019) |
| Weeks tracked | 372 |
| Tracking since | Aug 21, 2019 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the netarsudil and latanoprost ophthalmic solution, 0.02%/0.005% market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Alcon Laboratories, Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
netarsudil and latanoprost ophthalmic solution, 0.02%/0.005% market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of ROCKLATAN 0.02%-0.005% EYE DRP?
The current National Average Drug Acquisition Cost (NADAC) for ROCKLATAN 0.02%-0.005% EYE DRP, manufactured by Alcon Laboratories, Inc., is $139.4032 per ML (NDC 70727052925), effective Sep 30, 2026.
How has the price of ROCKLATAN 0.02%-0.005% EYE DRP changed over time?
Over the history we have for it, the NADAC for ROCKLATAN 0.02%-0.005% EYE DRP has risen 38.6%. It has been tracked across 372 weekly CMS publications since Aug 21, 2019.
What are the highest and lowest recorded NADAC prices for ROCKLATAN 0.02%-0.005% EYE DRP?
Since Aug 21, 2019, the NADAC for ROCKLATAN 0.02%-0.005% EYE DRP has ranged from a low of $100.5940 (Aug 21, 2019) to a high of $139.6392 (May 13, 2026), with a median of $126.6973 per ML.
Are there cheaper alternatives to ROCKLATAN 0.02%-0.005% EYE DRP?
No other NADAC-published product currently shares the active ingredient and strength of ROCKLATAN 0.02%-0.005% EYE DRP in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures ROCKLATAN 0.02%-0.005% EYE DRP?
ROCKLATAN 0.02%-0.005% EYE DRP (NDC 70727052925) is labeled by Alcon Laboratories, Inc., and CMS classifies it as a brand product.